Inhibitor development in one patient and laboratory discrepancies in several families with both mild haemophilia and Arg531Cys mutation.
about
Mild hemophilia A.Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development.Factor VIII genotype characterization of haemophilia A affected patients with transient and permanent inhibitors: a comprehensive Argentine study of inhibitor risks.Risk of inhibitor development in mild haemophilia A increases with age.
P2860
Inhibitor development in one patient and laboratory discrepancies in several families with both mild haemophilia and Arg531Cys mutation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Inhibitor development in one p ...... philia and Arg531Cys mutation.
@en
Inhibitor development in one p ...... philia and Arg531Cys mutation.
@nl
type
label
Inhibitor development in one p ...... philia and Arg531Cys mutation.
@en
Inhibitor development in one p ...... philia and Arg531Cys mutation.
@nl
prefLabel
Inhibitor development in one p ...... philia and Arg531Cys mutation.
@en
Inhibitor development in one p ...... philia and Arg531Cys mutation.
@nl
P2093
P1433
P1476
Inhibitor development in one p ...... philia and Arg531Cys mutation.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2516.2006.01422.X
P577
2007-03-01T00:00:00Z